Survey on therapy of multiple sclerosis: ACT-therapeutic adherence in patients with immunomodulatory disease-modifying therapies and factors potentially influencing treatment adherence

被引：0
|
作者：
Tackenberg, B. [1 ]
机构：
[1] Univ Marburg, Marburg, Germany
来源：
JOURNAL OF NEUROLOGY | 2011年 / 258卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：266 / 267
页数：2
相关论文
共 50 条
  • [41] Factors influencing adherence to disease-modifying drugs for multiple sclerosis: baseline data of an international observational study
    Pozzilli, C.
    Miltenburger, C.
    Bugge, J.
    Ecari, U.
    MULTIPLE SCLEROSIS, 2007, 13 : S135 - S135
  • [42] Adherence to Disease-Modifying Therapies in Patients with Relapsing Multiple Sclerosis: 2-Year Interim Results of the Global Adherence Project
    Arroyo, Estefania
    Grau, Cecilia
    Parra, Juan Carlos
    Solino, Olga Sanchez
    NEUROLOGY, 2010, 74 (09) : A546 - A546
  • [43] USING A PANEL SURVEY TO IDENTIFY PREDICTORS OF DISEASE-MODIFYING DRUG ADHERENCE IN PATIENTS WITH MULTIPLE SCLEROSIS
    Phillips, A. L.
    Kozma, C. M.
    Locklear, J. C.
    VALUE IN HEALTH, 2014, 17 (07) : A400 - A400
  • [44] Adherence to disease-modifying therapies in multiple sclerosis: Does caregiver social support matter?
    Siegel, Scott D.
    Turner, Aaron P.
    Haselkorn, Jodie K.
    REHABILITATION PSYCHOLOGY, 2008, 53 (01) : 73 - 79
  • [45] Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysis
    Zuckerman, Autumn D.
    DeClercq, Josh
    Simonson, Dana
    Zagel, Alicia L.
    Turco, Evan
    Banks, Aimee
    Wawrzyniak, Julie
    Rightmier, Elizabeth
    Blevins, Abbi
    Choi, Leena
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 75
  • [46] The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
    Devonshire, V.
    Lapierre, Y.
    Macdonell, R.
    Ramo-Tello, C.
    Patti, F.
    Fontoura, P.
    Suchet, L.
    Hyde, R.
    Balla, I.
    Frohman, E. M.
    Kieseier, B. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (01) : 69 - 77
  • [47] Adherence to Disease-Modifying Therapies in Spanish Patients with Relapsing Multiple Sclerosis: Two-Year Interim Results of the Global Adherence Project
    Arroyo, E.
    Grau, C.
    Ramo-Tello, C.
    Parra, J.
    Sanchez-Solino, O.
    EUROPEAN NEUROLOGY, 2011, 65 (02) : 59 - 67
  • [48] Factors that influence adherence with disease-modifying therapy in MS
    Katherine Treadaway
    Gary Cutter
    Amber Salter
    Sharon Lynch
    James Simsarian
    John Corboy
    Douglas Jeffery
    Bruce Cohen
    Ken Mankowski
    Joseph Guarnaccia
    Lawrence Schaeffer
    Roy Kanter
    David Brandes
    Charles Kaufman
    David Duncan
    Ellen Marder
    Arthur Allen
    John Harney
    Joanna Cooper
    Douglas Woo
    Olaf Stüve
    Michael Racke
    Elliot M. Frohman
    Journal of Neurology, 2009, 256 : 568 - 576
  • [49] Factors that influence adherence with disease-modifying therapy in MS
    Treadaway, Katherine
    Cutter, Gary
    Salter, Amber
    Lynch, Sharon
    Simsarian, James
    Corboy, John
    Jeffery, Douglas
    Cohen, Bruce
    Mankowski, Ken
    Guarnaccia, Joseph
    Schaeffer, Lawrence
    Kanter, Roy
    Brandes, David
    Kaufman, Charles
    Duncan, David
    Marder, Ellen
    Allen, Arthur
    Harney, John
    Cooper, Joanna
    Woo, Douglas
    Stuve, Olaf
    Racke, Michael
    Frohman, Elliot M.
    JOURNAL OF NEUROLOGY, 2009, 256 (04) : 568 - 576
  • [50] Improving adherence to injectable disease-modifying drugs in multiple sclerosis
    Bayas, Antonios
    EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (03) : 285 - 287
12345